Atypical Squamous Cells of the Cervix: Clinical Trials

28 trials for Atypical Squamous Cells of the Cervix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 terminated, 4 unknown, 3 recruiting. 9 Not applicable, 8 Phase 2, 3 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 4, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 28Completed 5, Terminated 2, Recruiting 1
Phase 13Completed 1, Recruiting 1, Terminated 1
Phase 31Completed 1
Phase 41Unknown 1

Follow Atypical Squamous Cells of the Cervix: new trials by email Literature Review of Atypical Squamous Cells of the Cervix trials Research Report on Atypical Squamous Cells of the Cervix

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV)
Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections
Not applicableNot yet recruitingHifas da Terra S.L.812027-07-012026-10-05
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities
EGCG and Quinine Sulfate Vaginal Suppository, Placebo - High-risk HPV (Any Strain), LSIL, Low Grade Squamous Intraepithelial Lesion
Phase 2RecruitingAmplexd Therapeutics, Inc.452026-04-302026-05-14
Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)
Oral Immunomodulator, Vaginal Ovule, Standard Supportive Care - Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia (CIN)
Not applicableActive not recruitingDr. Lutfi Kirdar Kartal Training and Research Hospital762026-04-282026-07-29
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Physical examination, Liquid-based cytology, Molecular screening - Atypical Squamous Cell of Undetermined Significance, ASC-US
Not applicableWithdrawnTimser SAPI de CV2026-02-272026-03-03
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Physical examination, Liquid-based cytology, Molecular screening - I) Atypical Squamous Cells of Undetermined Significance (ASC-US), II) Atypical Glandular Cells of Uncertain Significance (AGUS)
Not applicableRecruitingTimser SAPI de CV5582026-02-032026-03-18
Study of Treatment for HPV16+ ASC-US or LSIL
pNGVL4aCRTE6E7L2, TA-CIN - ASC-US, LSIL
Phase 1RecruitingUniversity of Alabama at Birmingham302023-07-102026-05-15
Primary Cervical Cancer Screening by Self-sampling HPV Test
Human Papillomavirus Infection, Cervical Cancer
Active not recruitingPeking University People's Hospital178752022-11-192023-12-21
Clinical Evaluation of Detection of High Risk HPV in Urine
Human Papillomavirus Infection, Cervical Cancer
UnknownPeking University People's Hospital10002021-09-152022-01-27
"Lactobacillus Crispatus M247, LSIL and Microbiota"
Lactobacillus Crispatus M247 - Vaginal Flora Imbalance, ASC-US
Phase 4UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS902021-06-162023-04-11
Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
PVX-2, Placebo - ASC-US, ASC-H
Phase 2TerminatedPapiVax Biotech, Inc.162019-05-222024-06-17
HPV Test of Urine and Self Collected Vaginal Samples for Cervical Cancer Screening Study
Flocked Swab, Cervical Brush, HPV assay - ASC-US, LSIL
UnknownKorea University Guro Hospital3002018-05-042018-08-24
Zinc Sulfate for Human Papillomavirus (HPV)
Zinc Sulfate, Placebo (Gelatin Tablet) - Human Papilloma Virus
Not applicableTerminatedCorewell Health West212017-10-242023-09-22
Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
GTL001+, Aldara - HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL
Phase 1TerminatedGenticel132015-08-012016-12-02
Probiotic Implementation as Help in Solving Vaginal Infections
Lactobacillus rhamnosus BMX 54 - Vaginal Infection, ASC-US
Phase 2CompletedUniversity of Roma La Sapienza1172015-02-012017-12-13
Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS?
Vitamin B12 and folate - ASC-US, Human Papilloma Virus
Not applicableCompletedSanliurfa Mehmet Akif Inan Education and Research Hospital2002014-05-012019-04-05
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
Cervical Papanicolaou Test, Cytology Specimen Collection Procedure, Questionnaire Administration - Atypical Squamous Cell of Undetermined Significance, Cervical Carcinoma
Not applicableCompletedUniversity of Washington13352012-03-012020-07-31
Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer
Immunotherapeutic GSK2302025A, different formulations - Melanoma
Phase 1CompletedGlaxoSmithKline1072010-07-022020-11-20
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
Immunotherapeutic GSK2132231A - Melanoma
Phase 2CompletedGlaxoSmithKline242009-05-192021-04-08
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
APTIMA HPV Assay, FDA-Approved HPV DNA Test - Human Papillomavirus Infection
Phase 3CompletedGen-Probe, Incorporated128962008-03-012017-01-06
Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171
Papanicolaou test, laboratory biomarker analysis - Cervical Cancer, Precancerous Condition
UnknownGynecologic Oncology Group552008-02-012010-11-08

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Uterine Cervical Dysplasia (14)  ·  Papillomavirus Infections (13)  ·  Uterine Cervical Neoplasms (13)  ·  Squamous Intraepithelial Lesions (11)  ·  Precancerous Conditions (6)  ·  Adenocarcinoma in Situ (2)  ·  Melanoma (2)  ·  Candidiasis, Vulvovaginal (1)  ·  Infections (1)  ·  Neoplasms (1)  ·  Vaginal Diseases (1)  ·  Vaginitis (1)

Broader conditions

Female Urogenital Diseases (28)  ·  Female Urogenital Diseases and Pregnancy Complications (28)  ·  Genital Diseases (28)  ·  Genital Diseases, Female (28)  ·  Morphological and Microscopic Findings (28)  ·  Pathological Conditions, Signs and Symptoms (28)  ·  Urogenital Diseases (28)  ·  Uterine Cervical Diseases (28)  ·  Uterine Diseases (28)  ·  Neoplasms (27)  ·  Precancerous Conditions (22)  ·  Neoplasms by Site (15)  ·  Uterine Cervical Dysplasia (14)  ·  Communicable Diseases (13)  ·  DNA Virus Infections (13)

Interventions

Colposcopy (2)  ·  Folic Acid (2)  ·  Human Papillomavirus DNA Tests (2)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (2)  ·  Restraint, Physical (2)  ·  Biopsy (1)  ·  Gelatin (1)  ·  High-Throughput Screening Assays (1)  ·  Imiquimod (1)  ·  Immunologic Factors (1)  ·  Mindfulness-Based Stress Reduction (1)  ·  Papanicolaou Test (1)  ·  Vaginal Smears (1)  ·  Vitamin B 12 (1)  ·  Zinc Sulfate (1)

Sponsors

GlaxoSmithKline (2)  ·  Peking University People's Hospital (2)  ·  Timser SAPI de CV (2)  ·  University of Alabama at Birmingham (2)  ·  University of Washington (2)  ·  AIDS Malignancy Consortium (1)  ·  Amplexd Therapeutics, Inc. (1)  ·  Corewell Health West (1)  ·  Dr. Lutfi Kirdar Kartal Training and Research Hospital (1)  ·  Eisenhower Army Medical Center (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Fox Chase Cancer Center (1)  ·  Gen-Probe, Incorporated (1)  ·  Genticel (1)  ·  Gynecologic Oncology Group (1)

Countries

United States (13)  ·  China (2)  ·  France (2)  ·  Italy (2)  ·  Mexico (2)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Russia (1)  ·  Senegal (1)  ·  South Korea (1)

Top investigators

Leopoldo E Gatica-Galina, MD in OB/GY & Gynecol Oncol (2)  ·  Bonnie Spring, PhD (1)  ·  Carolyn Fang, PhD (1)  ·  Chandrika J. Piyathilake, PhD, MPH (1)  ·  Dean A. Seehusen, MD, MPH (1)  ·  Frank Meyskens (1)  ·  Jae Kwan Lee, MD, Ph.D. (1)  ·  Jennifer L Reid, PhD (1)  ·  Joel Palefsky, MD (1)  ·  Kar Kei Yung, MBBS (HK), MRCOG, FHKCOG, FHKA (1)  ·  Keiichi Fujiwara, MD, PhD (1)  ·  Mark Einstein, MD, MS (1)  ·  Nancy B. Kiviat, MD (1)

Results publications

PMID 20812850, PMID 27843625, PMID 28332888, PMID 29304768, PMID 31264912, PMID 34907980, PMID 36607735

NIH funding

2008 (1), 2009 (1), P30CA015704 (1), P30CA060553 (1), R01CA111187 (1), R01CA125069 (1), R01CA157469 (1), R21CA126450 (1), U01CA121947 (1)